Amide-modified prenylcysteine based Icmt inhibitors: Structure–activity relationships, kinetic analysis and cellular characterization
- 1 January 2012
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 20 (1), 283-295
- https://doi.org/10.1016/j.bmc.2011.10.087
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: Sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand bindingNucleic Acids Research, 2009
- Solid-Phase Synthesis of Prenylcysteine AnalogsThe Journal of Organic Chemistry, 2009
- Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational ModificationJournal of Biological Chemistry, 2008
- Inactivating Icmt ameliorates K-RAS–induced myeloproliferative diseaseBlood, 2008
- A viable synthesis of N-methyl cysteinePeptide Science, 2007
- Combinatorial Modulation of Protein PrenylationACS Chemical Biology, 2007
- Therapeutic intervention based on protein prenylation and associated modificationsNature Chemical Biology, 2006
- Amide-substituted farnesylcysteine analogs as inhibitors of human isoprenylcysteine carboxyl methyltransferaseBioorganic & Medicinal Chemistry Letters, 2006
- A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) studyInvestigational New Drugs, 2005